Business Description
Incyte Corporation is a biopharmaceutical company founded in 1991 and based in Wilmington, Delaware, that discovers, develops, and sells treatments for cancers and other serious diseases across the United States, Europe, Canada, and Japan. The company markets several approved medicines targeting blood cancers, lymphomas, and graft-versus-host disease, while also advancing a broad pipeline of experimental treatments for conditions ranging from ovarian cancer to rare inflammatory diseases. Incyte works alongside partners such as Novartis, Lilly, and Syndax, and distributes its products through specialty pharmacies, hospital pharmacies, and distributors.
